Worldwide, colorectal cancer (CRC) is the third most common cancer, with the highest mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited by the inter-individual variability in drug response and the development of cancer cell resistance. ATP-binding cassette (ABC) transporters play a crucial role in the development of resistance by the efflux of anticancer agents outside of cancer cells. The aim of this study was to explore transcript levels of all human ABCs in tumours and non-neoplastic control tissues from CRC patients collected before the first line of treatment by 5-fluorouracil (5-FU)-containing regimen. The prognostic potential of ABCs was evaluated by the correlation of transcript levels with clinical factors. Relations between transcript levels of ABCs in tumours and chemotherapy efficacy were also addressed. The transcript profile of all known human ABCs was assessed using real-time polymerase chain reaction with a relative standard curve. The majority of the studied ABCs were down-regulated or unchanged between tumours and control tissues. ABCA12, ABCA13, ABCB6, ABCC1, ABCC2 and ABCE1 were up-regulated in tumours versus control tissues. Transcript levels of ABCA12, ABCC7 and ABCC8 increased in direction from colon to rectum. Additionally, transcript levels of ABCB9, ABCB11, ABCG5 and ABCG8 followed the reverse significant trend, i.e. a decrease in direction from colon to rectum. The transcript level of ABCC10 in tumours correlated with the grade (P = 0.01). Transcript levels of ABCC6, ABCC11, ABCF1 and ABCF2 were significantly lower in non-responders to palliative chemotherapy in comparison with responders. The disease-free interval of patients treated by adjuvant chemotherapy was significantly shorter in patients with low transcript levels of ABCA7, ABCA13, ABCB4, ABCC11 and ABCD4. In conclusion, ABCC11 may be a promising candidate marker for a validation study on 5-FU therapy outcome.

Toxicogenomics Unit National Institute of Public Health Srobarova 48 Prague 10 100 42 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12024064

003      

CZ-PrNML

005      

20171213085222.0

007      

ta

008      

120815s2012 enk f 000 0#eng||

009      

AR

024    7_

$a 10.1093/mutage/ger075 $2 doi

035    __

$a (PubMed)22294766

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Hlavata, I $u Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, Prague 10, 100 42 Czech Republic.

245    14

$a The role of ABC transporters in progression and clinical outcome of colorectal cancer / $c I. Hlavata, B. Mohelnikova-Duchonova, R. Vaclavikova, V. Liska, P. Pitule, P. Novak, J. Bruha, O. Vycital, L. Holubec, V. Treska, P. Vodicka, P. Soucek,

520    9_

$a Worldwide, colorectal cancer (CRC) is the third most common cancer, with the highest mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited by the inter-individual variability in drug response and the development of cancer cell resistance. ATP-binding cassette (ABC) transporters play a crucial role in the development of resistance by the efflux of anticancer agents outside of cancer cells. The aim of this study was to explore transcript levels of all human ABCs in tumours and non-neoplastic control tissues from CRC patients collected before the first line of treatment by 5-fluorouracil (5-FU)-containing regimen. The prognostic potential of ABCs was evaluated by the correlation of transcript levels with clinical factors. Relations between transcript levels of ABCs in tumours and chemotherapy efficacy were also addressed. The transcript profile of all known human ABCs was assessed using real-time polymerase chain reaction with a relative standard curve. The majority of the studied ABCs were down-regulated or unchanged between tumours and control tissues. ABCA12, ABCA13, ABCB6, ABCC1, ABCC2 and ABCE1 were up-regulated in tumours versus control tissues. Transcript levels of ABCA12, ABCC7 and ABCC8 increased in direction from colon to rectum. Additionally, transcript levels of ABCB9, ABCB11, ABCG5 and ABCG8 followed the reverse significant trend, i.e. a decrease in direction from colon to rectum. The transcript level of ABCC10 in tumours correlated with the grade (P = 0.01). Transcript levels of ABCC6, ABCC11, ABCF1 and ABCF2 were significantly lower in non-responders to palliative chemotherapy in comparison with responders. The disease-free interval of patients treated by adjuvant chemotherapy was significantly shorter in patients with low transcript levels of ABCA7, ABCA13, ABCB4, ABCC11 and ABCD4. In conclusion, ABCC11 may be a promising candidate marker for a validation study on 5-FU therapy outcome.

650    _2

$a ABC transportéry $x genetika $7 D018528

650    _2

$a senioři $7 D000368

650    _2

$a antitumorózní látky $x terapeutické užití $7 D000970

650    _2

$a studie případů a kontrol $7 D016022

650    _2

$a adjuvantní chemoterapie $7 D017024

650    _2

$a kolon $x metabolismus $7 D003106

650    _2

$a kolorektální nádory $x farmakoterapie $x genetika $x mortalita $7 D015179

650    _2

$a progrese nemoci $7 D018450

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a regulace genové exprese u nádorů $7 D015972

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a metastázy nádorů $7 D009362

650    _2

$a pilotní projekty $7 D010865

650    _2

$a prognóza $7 D011379

650    _2

$a messenger RNA $x genetika $7 D012333

650    _2

$a kvantitativní polymerázová řetězová reakce $7 D060888

650    _2

$a rektum $x metabolismus $7 D012007

650    _2

$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133

650    _2

$a míra přežití $7 D015996

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Mohelnikova-Duchonova, B

700    1_

$a Vaclavikova, R

700    1_

$a Liska, V

700    1_

$a Pitule, P

700    1_

$a Novak, P

700    1_

$a Bruha, J

700    1_

$a Vycital, O

700    1_

$a Holubec, Luboš, $d 1941- $7 skuk0003095

700    1_

$a Treska, V

700    1_

$a Vodicka, P

700    1_

$a Soucek, P

773    0_

$w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 27, č. 2 (2012), s. 187-96

856    41

$u https://pubmed.ncbi.nlm.nih.gov/22294766 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m $z 0

990    __

$a 20120815 $b ABA008

991    __

$a 20171213085410 $b ABA008

999    __

$a ok $b bmc $g 946212 $s 781392

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2012 $b 27 $c 2 $d 187-96 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429

GRA    __

$a NS10230 $p MZ0

LZP    __

$a Pubmed-20120815/12/02